Utility of Multiparametric Prostate MRI to Predict Regional or Distant Metastatic Disease Against Conventional Staging Using CT and Bone Scintigraphy or 68Ga-PSMA PET in Intermediate-to-High-Risk Prostate Cancer
The impression of nodal and metastatic status through mpMRI poorly correlates with results from conventional staging and PSMA-PET. PSMA-PET more often produces discordant results to mpMRI, signifying an additive diagnostic value. MRI should not be used alone in the workup of prostate cancer in patients with a GS ≥ 7, where metastasis is a concern.
Authors
- Minhtuan Nguyenhuy (ORCID: https://orcid.org/0000-0002-4546-2079)
- David Homewood (ORCID: https://orcid.org/0000-0002-6072-6191)
- Xiang Qian Chan
- Philip Dundee (ORCID: https://orcid.org/0000-0002-8581-5051)
- Cindy Ogluszko
- Niall M. Corcoran (ORCID: https://orcid.org/0000-0003-4483-6945)
Institutions
- The Royal Melbourne Hospital (AU)
- Western Health (AU)
- Austin Health (AU)
Publication Details
- Journal
- Cureus
- Published
- 2024-11-13
- DOI
- https://doi.org/10.7759/cureus.73607
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00